Multivariate Cox regression analysis, when confined to AML patients of intermediate and advanced stages (validation cohort, see Table 1), revealed a significantly reduced risk of relapse with higher pre-conditioning serum Leptin values (HR (95% CI): 0.84 (0.72–0.97); p = 0.020). This evidence concerns the gene LEP and acute myeloid leukemia.